Article Details
Retrieved on: 2025-02-26 19:01:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
HBV therapies developer Arbutus Biopharma Corp. (NASDAQ:ABUS) has named Lindsay Androski CEO and replaced its entire board.
Article found on: www.biocentury.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here